3/24
06:20 pm
nrxp
InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files 2025 Form 10-K And Highlights Operational Progress [TheStreet.com]
Low
Report
InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files 2025 Form 10-K And Highlights Operational Progress [TheStreet.com]
3/24
03:21 pm
nrxp
NRX Pharmaceuticals Inc (NRXP) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]
Low
Report
NRX Pharmaceuticals Inc (NRXP) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]
3/24
03:02 pm
nrxp
NRx Pharmaceuticals (NRXP) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $34.00 price target on the stock.
Low
Report
NRx Pharmaceuticals (NRXP) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $34.00 price target on the stock.
3/24
12:21 pm
nrxp
NRx Pharmaceuticals (NRXP) had its "buy" rating reaffirmed by BTIG Research. They now have a $25.00 price target on the stock.
Medium
Report
NRx Pharmaceuticals (NRXP) had its "buy" rating reaffirmed by BTIG Research. They now have a $25.00 price target on the stock.
3/24
10:42 am
nrxp
NRx Pharmaceuticals, Inc. (NRXP) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
NRx Pharmaceuticals, Inc. (NRXP) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/24
07:16 am
nrxp
NRx Pharmaceuticals GAAP EPS of -$1.34, revenue of $1.23M [Seeking Alpha]
High
Report
NRx Pharmaceuticals GAAP EPS of -$1.34, revenue of $1.23M [Seeking Alpha]
3/24
07:00 am
nrxp
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress
High
Report
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress
3/24
05:25 am
nrxp
NRx Pharmaceuticals Wraps Virtual Annual Meeting, Eyes Pivotal 2025 Earnings Call Ahead [Yahoo! Finance]
High
Report
NRx Pharmaceuticals Wraps Virtual Annual Meeting, Eyes Pivotal 2025 Earnings Call Ahead [Yahoo! Finance]
11/14/2025
04:32 pm
nrxp
nrx pharmaceuticals, inc.
MISS
Report
-13.2%
nrx pharmaceuticals, inc.
Ascendiant Capital Markets
3/24
04:32 pm
nrxp
Form 8-K NRX Pharmaceuticals, For: Mar 23
Low
Report
Form 8-K NRX Pharmaceuticals, For: Mar 23
3/23
04:31 pm
nrxp
Form 10-K NRX Pharmaceuticals, For: Dec 31
High
Report
Form 10-K NRX Pharmaceuticals, For: Dec 31
2/24
05:00 pm
nrxp
Form DEFA14A NRX Pharmaceuticals,
Low
Report
Form DEFA14A NRX Pharmaceuticals,
2/23
05:16 pm
nrxp
Form ARS NRX Pharmaceuticals, For: Dec 31
Medium
Report
Form ARS NRX Pharmaceuticals, For: Dec 31
2/23
05:01 pm
nrxp
Form DEF 14A NRX Pharmaceuticals, For: Mar 23
Medium
Report
Form DEF 14A NRX Pharmaceuticals, For: Mar 23
2/17
07:01 pm
nrxp
Form 4 NRX Pharmaceuticals, For: Jan 27 Filed by: Casper Joseph Michael
Low
Report
Form 4 NRX Pharmaceuticals, For: Jan 27 Filed by: Casper Joseph Michael
2/17
07:00 pm
nrxp
Form 3 NRX Pharmaceuticals, For: Jan 27 Filed by: Casper Joseph Michael
Low
Report
Form 3 NRX Pharmaceuticals, For: Jan 27 Filed by: Casper Joseph Michael
2/17
09:21 am
nrxp
Form 8-K NRX Pharmaceuticals, For: Feb 17
Medium
Report
Form 8-K NRX Pharmaceuticals, For: Feb 17
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register